Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Form 8.3 - DLAR LN

12 Jun 2025 15:00

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

De La Rue plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

11 June 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

44 152/175p ordinary

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

11,070,877

 

5.64%

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

11,070,877

 

5.64%

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

Number of securities

 

Price per unit

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

44 152/175p ordinary

 

CFD

 

Increasing a long position

 

579

 

129p

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

 

No

Date of disclosure:

 

12 June 2025

Contact name:

 

James Evans

Telephone number:

 

+44 20 3161 0743

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250612759338/en/

Copyright Business Wire 2025

Date   Source Headline
23rd Nov 20227:00 amRNS2022/23 HALF YEAR RESULTS
22nd Nov 202210:39 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSResponse to Crystal Amber's open letter
3rd Nov 20222:33 pmRNSNotice of GM
27th Oct 20221:00 pmRNSDE LA RUE PLC ANNOUNCES GENERAL MEETING
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSExtension of contract
13th Sep 202210:58 amRNSDirectorate Change
2nd Sep 20227:00 amRNSExecutive Changes in Authentication Division
1st Sep 202212:10 pmRNSDirector/PDMR Shareholding
10th Aug 20221:55 pmRNSDirector/PDMR Shareholding
1st Aug 202210:01 amRNSTotal Voting Rights
27th Jul 202211:53 amRNSResult of AGM
26th Jul 20225:11 pmRNSTERMINATION OF RELATIONSHIP AGREEMENT WITH PORTALS
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20221:47 pmRNSDirector/PDMR Shareholding
1st Jul 202210:46 amRNSBlock listing Interim Review
1st Jul 202210:40 amRNSTotal Voting Rights
24th Jun 202210:21 amRNSAnnual Financial Report
9th Jun 20221:38 pmRNSHolding(s) in Company
31st May 20229:25 amRNSHolding(s) in Company
25th May 20227:00 amRNSFY22 Full Year Results
23rd May 20221:03 pmRNSAdditional Listing
7th Apr 20227:00 amRNSTrading Update
1st Apr 202210:17 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSUpdate on Responsible Business Activities
11th Mar 202210:45 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPension Scheme funding update
1st Mar 202210:44 amRNSTotal Voting Rights
3rd Feb 20227:00 amRNSAuthentication Contract Win
1st Feb 20229:44 amRNSTotal Voting Rights
26th Jan 20222:46 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTrading and Turnaround Plan Update
12th Jan 20225:48 pmRNSChange in Director's Particulars
5th Jan 20224:37 pmRNSDirector/PDMR Shareholding
4th Jan 202212:06 pmRNSBlock listing Interim Review
4th Jan 202212:02 pmRNSTotal Voting Rights
1st Dec 202111:59 amRNSTotal Voting Rights
24th Nov 20217:00 amRNS2021/22 HALF YEAR RESULTS
1st Nov 202111:55 amRNSTotal Voting Rights
15th Oct 202110:08 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSTrading Statement
1st Oct 20212:24 pmRNSTotal Voting Rights
15th Sep 20217:00 amRNSAnnouncement Of Significant Expansion In Malta
1st Sep 202111:00 amRNSTotal Voting Rights
4th Aug 202111:30 amRNSHolding(s) in Company
2nd Aug 20219:58 amRNSTotal Voting Rights
29th Jul 20211:36 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.